US2009240079A1PendingUtilityA1

Pharmaceutical Composition for Treating or Preventing Degenerative and Inflammatory Diseases

63
Assignee: GWAG BYOUNG-JOOPriority: Apr 13, 2006Filed: Apr 9, 2009Published: Sep 24, 2009
Est. expiryApr 13, 2026(expired)· nominal 20-yr term from priority
A61P 9/10A61P 3/10A61P 43/00A61P 25/16A61P 29/00A61P 25/28A61P 17/02A61P 1/04A61K 31/606A61P 1/16A61P 13/12A61P 21/00A61P 19/02A61P 1/00A61K 31/196A61P 1/18A61K 31/136C07C 229/64C07C 227/18
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to a pharmaceutical composition useful for treating or preventing inflammatory disease and cell damage, and a method for treating or preventing inflammatory disease and cell damage. The present invention uses the 2-hydroxybenzoic acid derivative represented by the specific chemical formula or its pharmaceutically acceptable salt. The compound of the present invention is useful for treating or preventing cell damage and inflammatory disease including gastritis, gastric ulcer, pancreatitis, colitis, arthritis, diabetes, arteriosclerosis, nephritis, hepatitis, Alzheimer's disease, Parkinson's disease and Lou Gehrig's disease.

Claims

exact text as granted — not AI-modified
1 . 2-Acetoxy-5-[2-(4-trifluoromethyl-phenyl)-ethylamino]-benzoic acid and its pharmaceutically acceptable salts. 
   
   
       2 . A method for manufacturing 2-acetoxy-5-[2-(4-trifluoromethyl-phenyl)-ethylamino]-benzoic acid, comprising
 (S1) reacting 2-hydroxy-5-[2-(4-trifluoromethyl-phenyl)-ethylamino]-benzoic acid with di-tert-butyl dicarbonate;   (S2) reacting 5-{tert-butoxycarbonyl[2-(4-trifluoromethyl-phenyl)-ethyl]amino}-2-hydroxybenzoic acid, which is made in the (S1) step, with acetyl halide; and   (S3) removing tert-butoxycarbonyl group from 5-{tert-butoxycarbonyl[2-(4-trifluoromethyl-phenyl)-ethyl]amino}-2-acetoxybenzoic acid, which is made in the (S2) step.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.